Chemomab Therapeutics Ltd. (CMMB) Institutional Ownership & Insider Trading
13 institutions reported holding Chemomab Therapeutics Ltd. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 4 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CMMBChemomab Therapeutics Ltd.Follow CMMB — free
—
Price chart with a free account
- Market cap
- 7.5M
- P/E TTM
- 1.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters13 institutions held 0.1% of the shares. Across filers that reported both quarters, shares held changed +8.0%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 13 | 0 | +8.0% | 4 | 1 | 4 | 3 |
| Mar 26 | 15 | 0 | -6.5% | 6 | 3 | 3 | 3 |
| Dec 25 | 14 | 0 | -5.9% | 4 | 6 | 3 | 2 |
| Sep 25 | 10 | 0 | -90.8% | 1 | 1 | 8 | 5 |
| Jun 25 | 14 | 4 | +13.4% | 5 | 2 | 3 | 5 |
| Mar 25 | 17 | 4 | -10.3% | 7 | 1 | 3 | 0 |
| Dec 24 | 16 | 4 | -8.6% | 1 | 4 | 5 | 4 |
| Sep 24 | 15 | 5 | +69.8% | 4 | 6 | 1 | 6 |
Chemomab Therapeutics Ltd. — questions
- Who owns Chemomab Therapeutics Ltd. stock?
- 13 institutions reported Chemomab Therapeutics Ltd. shares in 13F filings for the quarter ended 2026-06-30. The largest: CITADEL ADVISORS LLC (0.0%), ADAR1 Capital Management, LLC (0.0%), KESTRA PRIVATE WEALTH SERVICES, LLC (0.0%).
- Are Chemomab Therapeutics Ltd. insiders buying or selling?
- 4 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Chemomab Therapeutics Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.